These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1855435)

  • 21. Determination and kinetic analysis of non-insulin mediated glucose uptake in type 1 (insulin-dependent) diabetes mellitus.
    Shumak SL; Gulan M; Zinman B; Gottesman IS
    Diabetologia; 1989 Jan; 32(1):28-33. PubMed ID: 2651186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.
    Klauser R; Schernthaner G; Prager R
    Diabetes Res Clin Pract; 1988 Sep; 5(3):185-90. PubMed ID: 3065016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.
    Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ
    Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
    Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE
    Metabolism; 1988 Jul; 37(7):640-4. PubMed ID: 3290622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate, lipid and amino acid metabolism of insulin-dependent diabetic patients regulated by an artificial beta-cell unit.
    Foss MC; Vlachokosta FV; Aoki TT
    Diabetes Res; 1989 May; 11(1):1-8. PubMed ID: 2695278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
    Lawson P; Home PD; Bergenstal R
    Diabetes; 1985 Aug; 34 Suppl 3():27-30. PubMed ID: 3894126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII).
    Micossi P; Bosi E; Cristallo M; Monti LD; Librenti MC; Petrella G; Galimberti G; Spotti D; Giudici G; Vergani C
    Acta Diabetol Lat; 1986; 23(2):155-64. PubMed ID: 3751449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes.
    Arnfred J; Schmitz O; Hother-Nielsen O; Orskov C; Beck-Nielsen H; Hermansen K; Christiansen JS; Alberti KG; Orskov H
    Diabet Med; 1988 Nov; 5(8):755-60. PubMed ID: 2905942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.
    Bagdade JD; Helve E; Taskinen MR
    Metabolism; 1991 May; 40(5):445-9. PubMed ID: 2023530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Diabetes Care; 1989 May; 12(5):319-24. PubMed ID: 2656140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin regulation of glucose and lipid metabolism in massive obesity.
    Del Prato S; Enzi G; Vigili de Kreutzenberg S; Lisato G; Riccio A; Maifreni L; Iori E; Zurlo F; Sergi G; Tiengo A
    Diabetologia; 1990 Apr; 33(4):228-36. PubMed ID: 2189770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.
    Koopmans SJ; Sips HC; Krans HM; Radder JK
    Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.